"Genes, Wilms Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genes at loci that are involved in the development of WILMS TUMOR. Included are human WT1 at 11p13 and human WT2 (MTACR1) at 11p15.
| Descriptor ID |
D016162
|
| MeSH Number(s) |
G05.360.340.024.340.375.249.420 G05.360.340.024.340.415.400.420
|
| Concept/Terms |
Genes, Wilms Tumor- Genes, Wilms Tumor
- Tumor Genes, Wilms
- Wilms' Tumor Genes
- Genes, Wilms' Tumor
- Tumor Genes, Wilms'
- Genes, Wilms
- Wilms Genes
- Wilms Tumor Genes
- Genes, Wilms'
- Genes, Wilm
- Genes, Wilm's
- Wilms' Genes
Genes, WT2 Wilms Tumor- Genes, WT2 Wilms Tumor
- MTACR1 Genes
- Gene, MTACR1
- Genes, MTACR1
- MTACR1 Gene
- WT2 Genes, Human
- Gene, Human WT2
- Genes, Human WT2
- Human WT2 Gene
- Human WT2 Genes
- WT2 Gene, Human
- Multiple Tumor-Associated Chromosome Region 1 Genes
- Multiple Tumor Associated Chromosome Region 1 Genes
|
Below are MeSH descriptors whose meaning is more general than "Genes, Wilms Tumor".
Below are MeSH descriptors whose meaning is more specific than "Genes, Wilms Tumor".
This graph shows the total number of publications written about "Genes, Wilms Tumor" by people in this website by year, and whether "Genes, Wilms Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genes, Wilms Tumor" by people in Profiles.
-
The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes. Pediatr Blood Cancer. 2023 05; 70 Suppl 2:e29984.
-
Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. Cell Rep Med. 2022 06 21; 3(6):100644.
-
Origins of DNA methylation defects in Wilms tumors. Cancer Lett. 2019 08 10; 457:119-128.
-
Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer. Tumori. 2013 Nov-Dec; 99(6):715-22.
-
Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia. 2012 Aug; 14(8):742-56.
-
Beyond morphology: minimal residual disease detection in acute myeloid leukemia. Curr Opin Hematol. 2012 Mar; 19(2):82-8.
-
Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer. 2011 Feb; 11(2):111-21.
-
WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. J Clin Oncol. 2011 Feb 20; 29(6):698-703.
-
Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest. 2011 Jan; 121(1):174-83.
-
Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiency--case report and review of the literature. Am J Med Genet A. 2010 Mar; 152A(3):732-6.